James A. Gow

Bromfenac Ophthalmic Solution 0.09% (Xibrom) for Postoperative Ocular Pain and Inflammation

Eric D. Donnenfeld, Edward J. Holland, Robert H. Stewart et al. · Ophthalmology · 2007 · 84 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +7

Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With <i>RPGR</i> Gene Variations

Lenore von Krusenstiern, Jiajun Liu, Eileen Liao et al. · JAMA Ophthalmology · 2023 · 56 citations · Full text

24-Hour Evaluation of the Ocular Distribution of ¹⁴ C-Labeled Bromfenac Following Topical Instillation into the Eyes of New Zealand White Rabbits

George A. Baklayan, Hal M. Patterson, Clara K. Song et al. · Journal of Ocular Pharmacology and Therapeutics · 2008 · 51 citations

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children

Mark B. Abelson, Gail Torkildsen, Jon I. Williams et al. · Clinical Therapeutics · 2009 · 45 citations

Allergy, Ophthalmology, Allergy Medicine +8

Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial

Robert E. MacLaren, Manuel Fischer, James A. Gow et al. · Nature Medicine · 2023 · 45 citations · Full text